Societal and policy aspects of the introduction of nanotechnology in healthcare

International Journal of Healthcare Technology and Management

Volumn 7, Issue 6, 2006, Pages 463-473

  Rickerby, David G ^a  

^a JOINT RESEARCH CENTRE   (Italy)

Author keywords

Biochips; Biosensors; Diagnostic systems; Drug delivery; Ethics; Gene therapy; Medical devices; Nanotechnology; Nanotubes; Regulation

Indexed keywords

ANTINEOPLASTIC AGENT; BIOMATERIAL; NANOPARTICLE; NANOTUBE;

ARTICLE; BIOCHIP; BIOCOMPATIBILITY; BIOENGINEERING; BIOMIMETICS; BIOPROSTHESIS; BIOSENSOR; DIAGNOSTIC TEST; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; HEALTH CARE POLICY; MEDICAL ETHICS; MEDICAL INSTRUMENTATION; MEDICAL TECHNOLOGY; MEDICOLEGAL ASPECT; NANOTECHNOLOGY; RISK REDUCTION; ROBOTICS; TISSUE ENGINEERING;

EID: 33748074792     PISSN: 13682156     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJHTM.2006.010411     Document Type: Article

References (42)

1. AIMDD (1990) 'Directive 90/385/EEC on active implantable medical devices', Official Journal of the European Communities, Vol. L 189, 20 July, pp.17-36.
2. Alexandidou, S. and Kiparissides, C. (2002) 'Nanotechnology in medicine and health', in M.C. Roco and R. Tomellini (Eds) 3rd Joint EC-NSF Workshop on Nanotechnology, Lecce.
3. Arnal, A.H. (2003) Future Technologies, Today's Choices, London: Greenpeace Environmental Trust.
4. Bock, A-K., Ibarreta, D., Lheureux, K., Libeau, M., Nilsagård, H. (2001) 'Data is destiny: healthcare and human genomics', Foresight, Vol. 3, pp.377-388.
5. Brock, T. and Stopford, W. (2003) 'Bioaccessibility of metals in human health risk assessment: evaluating risk from exposure to cobalt compounds', Journal of Environmental Monitoring, Vol. 5, pp.71N-76N.
6. Byrne, M.E., Park, K. and Peppas, N.A. (2002) 'Molecular imprinting with hydrogels', Advanced Drug Delivery Reviews, Vol. 54, pp.149-161.
7. COM (2000) 'Communication from the commission on the precautionary principle', 02.02.2000, No. 1, European Commission, Brussels.
8. DG Enterprise (2002) 'Consultative document: need for a legislative framework for human tissue engineering and tissue engineered products', European Commission, DG Enterprise.
9. Directive 2001/20/EC (2001a) 'Directive 2001/20/EC on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use', Official Journal of the European Communities, Vol. L 121, 1 May, pp.34-44.
10. Directive 2001/83/EC (2001b) 'Directive 2001/83/EC on the community code relating to medicinal products for human use', Official Journal of the European Communities, Vol. L 311, 28 November, pp.67-128.
11. Directive 2004/27/EC (2004) 'Directive 2004/27/EC amending directive 2001/83/EC on the community code relating to medicinal products for human use', Official Journal of the European Communities, Vol. L 136, 30 April, pp.34-57.
12. European Commission (2003) 'Nanotechnology: opportunity or threat', CORDIS RTD-News, RCN 20401.
13. Felten, R. and Hussla, I. (2000) 'Microsystem and nanotechnologies applied for health: a 15-year perspective', Gesellschaft für Technologieförderung Itzehoe.
14. Freitas, R.A. (1999) Nanomedicine Volume 1: Basic Capabilities, Georgetown Texas: Landes Bioscience.
15. IVDD (1998) 'Directive 98/79/EC on in vitro diagnostic medical devices', Official Journal of the European Communities, Vol. L331, 7 December, pp.1-37.
16. LaVan, D.A. and Langer, R. (2000) 'Implications of nanotechnology in the pharmaceutics and medical fields', in M.C. Roco and W.S. Bainbridge (Eds) NSF Societal Implications of Nanoscience and Nanotechnology Workshop.
17. Malanowski, N. (2001) 'Study for an innovations and technological analysis on nanotechnology', VDI Technology Centre, Future Technologies Division.
18. Malsch, I. (2002) 'Biomedical applications of nanotechnology', The Industrial Physicist, June-July, pp.15-17.
19. McGregor, D.B., Baan, R.A., Partensky, C., Rice, J.M. and Wilbourn, J.D. (2000) 'Evaluation of the carcinogenic risks to humans associated with surgical implants and other foreign bodies - a report of an IARC monographs programme meeting', European Journal of Cancer, Vol. 36, pp.307-313.
20. MDD (1993) 'Directive 93/42/EEC on medical devices', Official Journal of the European Communities, Vol. L 169, 12 July, pp.1-43.
21. Mnyusiwalla, A., Daar, A.S. and Singer, P.A. (2003) 'Mind the gap: science and ethics in nanotechnology', Nanotechnology, Vol. 14, pp.R9-R13.
22. Moore, R. (2004) 'Overcoming regulatory and other challenges', International Conference on Nanotechnology and Smart Materials for Medical Devices: from Medical Diagnostics to Therapy, Rome.
23. Morrison, M. (Ed) (2003) 'Nanotechnology and its implications for the health of the EU citizen', Nanoforum Report.
24. Mosterin, J. (2002) 'Ethical implications of nanotechnology', in M.C. Roco and R. Tomellini (Eds) 3rd Joint EC-NSF Workshop on Nanotechnology, Lecce.
25. Oger, G. (2003) 'Parliament examines nanotech's potential problems', Small Times, Vol. 3, No. 5, p. 17.
26. Oud, M. and Malsch, I. (2003) 'Socioeconomic report on nanotechnology and smart materials for medical devices', Nanoforum Report.
27. Peterson, C. (2003) 'Molecular manufacturing: societal implications of advanced technology', Foresight Update, No. 52, pp.3-4.
28. Raffensberger, C. and Tickner, J. (Eds) (1999) Protecting Public Health and the Environment: Implementing the Precautionary Principle, Washington, DC: Island Press.
29. Rickerby, D.G. (2004) 'Regulatory issues in connection with nanotechnological medical devices', International Conference on Nanotechnology and Smart Materials for Medical Devices: from Medical Diagnostics to Therapy, Rome.
30. Roco, M.C. and Bainbridge, W.S. (Eds) (2001) Societal Implications of Nanoscience and Nanotechnology, Dordrecht: Kluwer.
31. Roco, M.C. and Bainbridge, W.S. (2002a) 'Converging technologies for improving human performance: integrating from the nanoscale', Journal of Nanoparticle Research, Vol. 4, pp.281-295.
32. Roco, M.C. and Bainbridge, W.S. (Eds) (2002b) Converging Technologies for Improving Human Performance, Arlington, VA: National Science Foundation.
33. Roco, M.C. and Tomellini, R. (Eds) (2002) 3rd Joint EC-NSF Workshop on Nanotechnology - Nanotechnology Revolutionary Opportunities and Societal Implications, Lecce.
34. Small Wonders, Endless Frontiers - A Review of the National Nanotechnology Initiative (2002) Washington, DC: National Academy Press.
35. Stayton, P.S., Hoffman, A.S., Murthy, N., Lackey, C., Cheung, C., Tan, P., Klumb, L.A., Chilkoti, A., Wilbur, F.S. and Press, O.W. (2000) 'Molecular engineering of proteins and polymers for targetting the intracellular delivery of theraputics', Journal of Controlled Release, Vol. 65, pp.203-220.
36. The European Group on Ethics in Science and New Technologies (2000) Genetic Testing in the Workplace, Luxembourg Office for Official Publications of the European Communities.
37. The Royal Society (2004) 'Nanoscience and nanotechnologies: opportunities and uncertainties', RS Policy Document 19/04.
38. Thumm, N., Steg, H. and Witelegg, C. (2000) 'The impact of single market regulation on innovation: regulatory reform and experiences of firms in the medical device industry', EUR 19734 EN, IPTS, JRC Seville.
39. UK Foresight Programme, Health and Ageing Population Panels (2000) Foresight, Making the Future Work for You, London: Department of Trade and Industry.
40. Whelan, J. (2001) 'Nanocapsules for controlled drug delivery', Drug Discovery Today, Vol. 6, pp.1183-1184.
41. Wilson, M.R., Lightbody, J.H., Donaldson, K., Sales, J. and Stone, V. (2002) 'Interactions between ultrafine particles and transition metals in vivo and in vitro', Toxicology and Applied Pharmacology, Vol. 184, pp.172-179.
42. Wood, S., Jones, R. and Geldart, A. (2003) The Social and Economic Challenges of Nanotechnology, Swindon: Economic and Social Research Council.